Search

Your search keyword '"Bailey, R. L."' showing total 60 results

Search Constraints

Start Over You searched for: Author "Bailey, R. L." Remove constraint Author: "Bailey, R. L." Database MEDLINE Remove constraint Database: MEDLINE
60 results on '"Bailey, R. L."'

Search Results

1. Writhed Analytical Magnetic Flux Rope Model.

2. Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity.

3. Follicular trachoma and trichiasis prevalence in an urban community in The Gambia, West Africa: is there a need to include urban areas in national trachoma surveillance?

4. Literacy, education and adherence to antiretroviral therapy in The Gambia.

5. Host genetic studies in human ocular Chlamydial infection.

6. Host genetic contribution to the cellular immune response to Chlamydia trachomatis: Heritability estimate from a Gambian twin study.

7. Risk factors for active trachoma in The Gambia.

8. Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians.

9. Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection.

10. A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia.

11. Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci.

12. Long term outcome of trichiasis surgery in the Gambia.

13. An index of community ocular Chlamydia trachomatis load for control of trachoma.

14. Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.

15. Characterization of the humoral immune response to Chlamydia outer membrane protein 2 in chlamydial infection.

16. Plummeting lenses in the TB clinic.

17. Longitudinal study of trachomatous trichiasis in the Gambia.

18. Azithromycin for the treatment and control of trachoma.

19. Natural history of trachomatous scarring in The Gambia: results of a 12-year longitudinal follow-up.

20. Human and other faeces as breeding media of the trachoma vector Musca sorbens.

21. Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis.

22. Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana.

23. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.

24. Failure to detect HLA-A*6802-restricted CD8+ T cells specific for Chlamydia trachomatis antigens in subjects from trachoma-endemic communities.

25. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.

26. Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis--endemic population.

27. Review of the evidence base for the 'F' and 'E' components of the SAFE strategy for trachoma control.

28. Should trichiasis surgery be offered in the village? A community randomised trial of village vs. health centre-based surgery.

29. Transmission ecology of the fly Musca sorbens, a putative vector of trachoma.

30. Effect of fly control on trachoma and diarrhoea.

32. The "dural tail sign": not always a meningioma.

33. Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma.

34. Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma.

35. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid.

36. Synthetic peptides based on Chlamydia trachomatis antigens identify cytotoxic T lymphocyte responses in subjects from a trachoma-endemic population.

37. HLA class I and II polymorphisms and trachomatous scarring in a Chlamydia trachomatis-endemic population.

38. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring.

39. Effects of azithromycin on malariometric indices in The Gambia.

40. Extent and kinetics of genetic change in the omp1 gene of Chlamydia trachomatis in two villages with endemic trachoma.

41. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls.

42. Molecular epidemiology of trachoma in a Gambian village.

43. Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities.

44. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens.

45. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective.

46. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

47. Genotyping of Chlamydia trachomatis from a trachoma-endemic village in the Gambia by a nested polymerase chain reaction: identification of strain variants.

48. A longitudinal study of trachoma in a Gambian village: implications concerning the pathogenesis of chlamydial infection.

49. Rapid method for processing soil samples for polymerase chain reaction amplification of specific gene sequences.

50. Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.

Catalog

Books, media, physical & digital resources